| 12/31/2014 | CV | Outlook 2015: Cheaper pricing, strong issuance eyed after convertibles pull back from 2014 levels
|
| 11/14/2014 | BKCVDDEMHY | Prospect News reports four new defaults for week of Nov. 6 to Nov. 12
|
| 11/12/2014 | CV | Market Commentary: New Isis Pharmaceuticals trades below par, slips on hedge; Dendreon steady; Home Inns adds
|
| 11/12/2014 | CV | Market Commentary: Morning Commentary: New Isis trades below par, slips on hedge; Dendreon trading at 55.5
|
| 11/10/2014 | CVDD | Dendreon files for Chapter 11, convertibles to be exchanged for stock
|
| 11/10/2014 | CV | Market Commentary: Dendreon drops after bankruptcy filing; Salix recoups some; Isis Pharmaceuticals on tap
|
| 11/10/2014 | CV | Market Commentary: Morning Commentary: Dendreon drops after bankruptcy filing; Salix Pharmaceuticals bounces slightly
|
| 11/10/2014 | CVDD | Dendreon files for Chapter 11, convertibles to be exchanged for stock
|
| 8/13/2014 | CVDD | Dendreon doubts ability to repay 2.875% convertibles, explores options
|
| 8/12/2014 | CV | Market Commentary: New Aegerion flat to better amid weak shares; Nuance bonds active after earnings, call
|
| 5/8/2014 | CV | Market Commentary: Cobalt gains on debut; existing Cobalt slips; Molycorp slides after earnings; Insulet adds
|
| 1/14/2014 | CV | Market Commentary: Midday Commentary: Hutchinson higher after preliminary earnings; Dendreon moves up to 70
|
| 1/14/2014 | CV | Market Commentary: Hutchinson, Dendreon higher after preliminary earnings; Goodrich looks rich; Intel active
|
| 10/28/2013 | CV | Market Commentary: Midday Commentary: NQ Mobile in focus after fraud allegations; Qihoo, Ctrip.com under pressure
|
| 10/28/2013 | CV | Market Commentary: NQ Mobile rises on parity basis as shares slide again; Qihoo, Ctrip.com down on hedge
|
| 9/27/2013 | CV | Market Commentary: Midday Commentary: Alpha Natural flat after Goldman upgrade; Dendreon eyed on positive drug data
|
| 9/27/2013 | CV | Market Commentary: Tower Group tumbles; UAL preferreds outperform shares; Alpha Natural flat after upgrade
|
| 8/30/2013 | CV | Market Commentary: AMR gains altitude as judge sets November anti-trust court date; Dendreon notes higher
|
| 8/16/2013 | CV | Market Commentary: New JDS Uniphase jumps after pricing on rich end; Merrimack extends slide; AMR wanes
|
| 8/13/2013 | CV | Market Commentary: AMR stumbles after Justice moves to block merger; new Rambus edges up outright, on swap
|
| 8/12/2013 | CV | Market Commentary: Tesla down outright, better dollar neutral; Dendreon weakens; Web.com adds; Rambus on tap
|
| 8/9/2013 | CV | Market Commentary: Web.com prices deal; YRC falls as Credit Suisse hired; Dendreon declines; MolyCorp drops
|
| 8/5/2013 | CV | Market Commentary: MOVE launches convertible offering; trader says primary primed for surge in new issues
|
| 6/21/2013 | CV | Market Commentary: Convertibles heavier as fear dominates tone; bank preferreds down; IG paper lower in line
|
| 5/10/2013 | CV | Market Commentary: Theravance mixed on COPD drug approval; Meritor improves; Electronic Arts extends gains
|
| 5/9/2013 | CV | Market Commentary: Electronic Arts convertibles gain on hedge; CACI, WebMD bid higher; Dendreon disappoints
|
| 3/22/2013 | CV | Market Commentary: Convertibles quiet; Walter improves on hedge; MGIC slips on hedge; Dendreon wavers
|
| 2/20/2013 | CV | Market Commentary: Dendreon, Goodrich pull back; Forestar sells $110 million bonds; Post looks slightly cheap
|
| 1/14/2013 | CV | Market Commentary: Dendreon adds outright; InterMune intends to price notes, shares; Lennar earnings on tap
|
| 12/11/2012 | CV | Market Commentary: WebMD active, unchanged as shares surge; AMR firms; Cobalt to price $1.2 billion offering
|
| 12/10/2012 | CV | Market Commentary: Bottomline extends gains; Dendreon adds about a point; A123 surges on auction; Molycorp up
|
| 11/5/2012 | CV | Market Commentary: BioMarin up on drug data; Walter Investment pulls back; convertibles pause for elections
|
| 11/2/2012 | CV | Market Commentary: Dendreon higher after wider loss; Vertex up on hedge after earnings miss; Chesapeake quiet
|
| 10/29/2012 | CV | Market Commentary: Convertibles silent: U.S. equity, bond markets shut as Sandy approaches; data delays eyed
|
| 7/31/2012 | CV | Market Commentary: Dendreon drops back into 60s on restructuring; ADM flat; Standard Pacific offering on tap
|
| 7/30/2012 | CV | Market Commentary: Convertibles mostly quiet; Kodak gains ahead of auction; Navistar firms; SanDisk mixed
|
| 7/24/2012 | CV | Market Commentary: WebMD down on warning; Dendreon better on takeout rumor; Virgin Media tighter after earnings
|
| 7/3/2012 | CV | Market Commentary: Convertibles quiet ahead of holiday; Lincare, Theravance extend gains; U.S. Steel better
|
| 6/13/2012 | CV | Market Commentary: New United Technologies units trade at 51; USEC up on DOE cost-sharing deal; Dendreon flat
|
| 6/5/2012 | CV | Market Commentary: Central European drops on restatement news; Illumina comes in slightly; Medicines Co. on tap
|
| 6/4/2012 | CV | Market Commentary: Convertibles see broad-based action; Dendreon down after rival's drug news; Salesforce steady
|
| 5/17/2012 | CV | Market Commentary: Dendreon declines after J&J drug news; Patriot Coal keeps sliding; Chesapeake lower again
|
| 5/9/2012 | CV | Market Commentary: Reoffered Annaly steady; Chiquita down after earnings; Human Genome unfazed by hostile bid
|
| 5/8/2012 | CV | Market Commentary: Thompson Creek slides; Annaly on tap; Dendreon drops outright, on hedge; Salix seen flat
|
| 3/27/2012 | CV | Market Commentary: Lennar flat to slightly higher on hedge on earnings; Radian steady; Dendreon catches a bid
|
| 3/19/2012 | CV | Market Commentary: Vornado finds buyers, trades with premium; BPZ adds; United States Steel gains 0.25 point on hedge
|
| 3/8/2012 | CV | Market Commentary: Navistar weaker on hedge after outlook cut; Dendreon drops 2 points on positive J&J drug study
|
| 2/27/2012 | CV | Market Commentary: Dendreon drops on outlook; Cheniere gains on Blackstone investment; DealerTrack to price
|
| 2/7/2012 | CV | Market Commentary: Coinstar jumps after earnings, Verizon deal; Dendreon edges slightly higher after pop
|
| 1/25/2012 | CV | Market Commentary: Illumina 'rips' higher outright, expands on hedge; Life, Human Genome move in sympathy
|
| 1/9/2012 | CV | Market Commentary: Convertibles revert to 'quiet'; Alcoa firm to better ahead of earnings; Amgen steady
|
| 1/6/2012 | CV | Market Commentary: Convertibles start year strong; Regeneron jumps to 104; Dendreon gains; RF Micro drops
|
| 1/5/2012 | CV | Market Commentary: Dendreon jumps on better Provenge sales; three Equinix convertibles add; Kodak lower
|
| 12/30/2011 | CV | Outlook 2012: Convertibles poised for modest gains after 2011's mostly negative returns
|
| 12/6/2011 | CV | Market Commentary: Dendreon adds on sale of royalty interest; Gilead trades on debt offering; Clearwire jumps
|
| 11/3/2011 | CV | Market Commentary: Jefferies extends losses; New Human Genome paper flat dollar neutral; MGM adds premium
|
| 9/28/2011 | CV | Market Commentary: Stillwater still falling after debt sale delayed; Horizon Lines extends exchange deadline
|
| 9/13/2011 | CV | Market Commentary: InterMune looks rich on revised terms; US Airways' premium comes in a point; Best Buy dips
|
| 9/9/2011 | CV | Market Commentary: Convertibles under pressure as equities drop; Amerigroup, RadioShack lower; Dendreon flat
|
| 8/9/2011 | CV | Market Commentary: Convertibles whip around; Hercules Offshore adds; Dendreon eases dollar neutral, MGM flat
|
| 8/5/2011 | CV | Market Commentary: Convertibles see limited bargain hunting; Vertex up on short covering; high grade firms
|
| 8/4/2011 | CV | Market Commentary: Convertibles plummet; PMI flickering out; Central European Distribution paper moves lower
|
| 5/3/2011 | CV | Market Commentary: Mylan off outright, expands on hedge; Incyte premium comes in; Alaska Communications on tap
|
| 4/21/2011 | CV | Market Commentary: Gilead, United Continental slip; Dendreon, WebMD, GM islands of activity in quiet session
|
| 4/14/2011 | CV | Market Commentary: Dendreon slips a point on hedge; Medtronic Bs add as As hit maturity; Sunrise deal on tap
|
| 4/4/2011 | CV | Market Commentary: Horizon Lines takes another leg down; Life Technologies slips; Dendreon up; Meritor steady
|
| 3/31/2011 | CV | Market Commentary: Greenbrier expands on debut; Ramco-Gershenson to price; Dendreon in line on drug news
|
| 3/11/2011 | CV | Market Commentary: Convertibles market eyes new paper; week sees more than $2 billion of issuance; Cemex off
|
| 2/3/2011 | CV | Dendreon greenshoe lifts 2.875% convertibles due 2016 to $620 million
|
| 1/18/2011 | CV | Market Commentary: Dendreon firm on stock outlook; Kinross maintains guidance; Symantec upgraded; Ares plans deal
|
| 1/14/2011 | CV | New Issue: Dendreon prices upsized $540 million five-year convertible notes at 2.875%, up 40%
|
| 1/14/2011 | CV | Market Commentary: Dendreon gains with stock after aggressive pricing; Intel results lift techs; Nielsen ahead
|
| 1/13/2011 | CV | Dendreon to price $500 million five-year convertibles to yield 2.375%-2.875%, up 40%-45%
|
| 1/13/2011 | CV | Market Commentary: Dendreon to price $500 million convertibles; Allergan active amid possible short covering
|
| 12/23/2010 | CVLM | Dendreon to exchange shares for $24.85 million of 4.75% convertibles
|
| 5/5/2009 | CV | Dendreon to issue shares in exchange for $21.22 million of its 4.75% convertibles due 2014
|
| 4/28/2009 | CV | Market Commentary: U.S. Steel, SunPower price; financials ease amid stress test chatter; Smithfield trades off
|
| 6/11/2008 | CVHY | Dendreon files $300 million shelf registration
|
| 12/13/2007 | CV | Market Commentary: Convertibles see light volume amid quiet session; A&P leads corporates issuing paper
|
| 6/6/2007 | CV | New Issue: Dendreon prices $75 million seven-year convertibles cheaper than talk at 4.75%, up 17.5%
|
| 6/6/2007 | CV | Market Commentary: Integra leads new deals with debut gain; Ciena gains dollar-neutral; Dendreon, Cogent set cheaper than talk
|
| 6/5/2007 | CV | Market Commentary: Amylin gains on debut; Integra higher, Ciena, Dendreon quiet in gray; Cogent, Panda launch unusual deals
|
| 6/4/2007 | CV | Dendreon talks $75 million seven-year convertibles at 3.5%-4%, up 20%-25%, to price Tuesday
|
| 6/4/2007 | CV | Market Commentary: Solectron surges on buyout; Amylin flat in gray; Dendreon faces borrow problem; Integra, Ciena plan deals
|
| 3/19/2007 | CV | Dendreon files $200 million shelf registration
|
